Literature DB >> 10632540

Effect of nifedipine administration (10 mg) on esophageal acid exposure time.

H Ishikawa1, K Iwakiri, T Sugiura, M Kobayashi.   

Abstract

The effect of nifedipine administration (10 mg) on esophageal acid exposure time was investigated in 11 non-reflux esophagitis (non-RE) patients and 11 grade C (Los Angeles classification) reflux esophagitis (RE) patients. In each subject, esophageal pH monitoring was performed, with the subject in the supine position, preprandially (1 h) and 3-h postprandially after oral administration of a placebo in the morning and oral administration of nifedipine (10 mg) in the afternoon on the same day. In the non-RE patients, there was no difference in the esophageal acid exposure time between administration of the placebo and that of nifedipine. In patients with RE, the esophageal acid exposure time after the administration of nifedipine was significantly (P<0.05) longer than that after the placebo. In patients with severe RE, the severity of RE may worsen with nifedipine administration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632540     DOI: 10.1007/s005350050008

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  4 in total

1.  Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan.

Authors:  Masatoshi Niigaki; Kyoichi Adachi; Kazuya Hirakawa; Kenji Furuta; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2012-09-14       Impact factor: 7.527

2.  Effects of anti-hypertensive drugs on esophageal body contraction.

Authors:  Koichi Yoshida; Kenji Furuta; Kyoichi Adachi; Shunji Ohara; Terumi Morita; Takashi Tanimura; Shuji Nakata; Masaharu Miki; Kenji Koshino; Yoshikazu Kinoshita
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

3.  Calcium channel blockers and esophageal sclerosis: should we expect exacerbation of interstitial lung disease?

Authors:  Charalampos Seretis; Fotios Seretis; George Gemenetzis; Nikolaos Liakos; Apostolos Pappas; Stavros Gourgiotis; Emmanuel Lagoudianakis; Dimitrios Keramidaris; Nikolaos Salemis
Journal:  Case Rep Gastroenterol       Date:  2012-01-31

4.  Association of medications for lifestyle-related diseases with reflux esophagitis.

Authors:  Daisuke Asaoka; Akihito Nagahara; Mariko Hojo; Kenshi Matsumoto; Hiroya Ueyama; Kohei Matsumoto; Kentaro Izumi; Tsutomu Takeda; Hiroyuki Komori; Yoichi Akazawa; Yuji Shimada; Taro Osada; Sumio Watanabe
Journal:  Ther Clin Risk Manag       Date:  2016-10-04       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.